Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEXO.L Regulatory News (EXO)

  • There is currently no data for EXO

Acquisition

11 Apr 2017 15:30

RNS Number : 2115C
Exova Group PLC
11 April 2017
 

 

STOCK EXCHANGE RELEASE

 

11 April 2017

Exova Group plc

 

Exova acquires SL Pharma Labs Incorporated

 

Exova Group plc ("Exova") EXO.L, the global testing, calibration and advisory services provider, has acquired SL Pharma Labs Incorporated (SL Pharma), a Delaware, US, based business that provides laboratory and clinical manufacture testing services to pharmaceutical, biotechnology and medical device companies.

Founded in 1997, SL Pharma has built a strong reputation in the provision of high value and high quality pharmaceutical product development and testing services focused primarily on the development and clinical manufacture of parenteral, ophthalmic, intranasal and topical drug products. The business has a team of 14 specialists and achieved revenues of around $2.5m in 2016.

Ian El-Mokadem, Chief Executive Officer at Exova, said: "This acquisition complements our existing operations by enhancing Exova's technical expertise in pharmaceutical services and offers a great foundation for further growth in North America. SL Pharma's addition to our portfolio clearly demonstrates our commitment to providing more technically demanding services and developing our capabilities in new markets."

 

ENDS

 

 

Enquiries:

 

Andy Jones

Powerscourt

T: +44 (0) 20 7549 0747

E: andy.jones@exova.com

 

Andrew Pickup

Corporate Affairs Director, Exova Group plc

T: +44 (0) 7920 243 393

E: andrew.pickup@exova.com

Exova

 

Exova is one of the world's leading laboratory-based testing groups, trusted by organisations to test and advise on the safety, quality and performance of their products and operations. Headquartered in Edinburgh, UK, Exova operates 135 laboratories and offices in 33 countries and employs around 4,200 people throughout Europe, the Americas, the Middle East, Asia/Asia Pacific and Africa.

Exova's capabilities help to extend asset life, bring predictability to applications, and shorten the time to market for customers' products, processes and materials. With over 90 years' experience, Exova specialises in testing across a number of key sectors ranging from Aerospace to Fire & Building Products; Oil & Gas and Industrials; Infrastructure & Environment; Transportation; and Health Sciences.

Exova Group plc is registered in England (registration number 08907086). Its legal entity identifier ('LEI') number is 213800BFE317FGSYMZ19.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQBBGDSSGBBGRB
Date   Source Headline
29th Jun 201711:22 amRNSForm 8.5 (EPT/RI)
29th Jun 201710:41 amRNSScheme of Arrangement becomes effective
28th Jun 20174:53 pmRNSTR1: Notification of Major Interest in Shares
28th Jun 20173:30 pmRNSForm 8.3 - EXO LN
28th Jun 20172:52 pmRNSForm 8.5 (EPT/RI)
28th Jun 20172:27 pmBUSForm 8.3 - Exova Group Plc
28th Jun 20171:45 pmRNSForm 8.3 - [Exova Group Plc]
28th Jun 20171:25 pmRNSForm 8.3 - Exova Group PLC
28th Jun 201712:11 pmRNSCourt Approval of Scheme
28th Jun 201711:17 amRNSForm 8.3 - Exova Group Plc
27th Jun 20176:00 pmRNSSuspension - Exova Group PLC
27th Jun 20173:30 pmRNSForm 8.3 - EXO LN
27th Jun 20173:09 pmRNSForm 8.3 - Exova Group Plc
27th Jun 20171:51 pmRNSTR-1: Notification of Major Interest in Shares
27th Jun 20171:40 pmRNSForm 8.3 - EXOVA GROUP PLC
27th Jun 201710:26 amRNSTR-1: Notification of Major Interest in Shares
27th Jun 20179:38 amRNSForm 8.3 - Exova Group Plc
27th Jun 20179:34 amRNSForm 8.3 - Exova Group Plc
26th Jun 20174:50 pmRNSDirectorate Change
26th Jun 20174:20 pmRNSForm 8.3 - Exova Group Plc
26th Jun 20173:30 pmRNSForm 8.3 - EXO LN
26th Jun 20172:46 pmBUSForm 8.3 - Exova Group plc
26th Jun 201710:36 amRNSForm 8.5 (EPT/RI)
26th Jun 201710:31 amRNSSuspension of trading of Exova Shares
26th Jun 201710:16 amRNSForm 8.5 (EPT/RI)
23rd Jun 20173:01 pmRNSForm 8.3 - Exova Group Plc
22nd Jun 201711:00 amRNSForm 8.5 (EPT/RI)
22nd Jun 20179:57 amRNSForm 8.5 (EPT/RI)
21st Jun 20172:26 pmRNSForm 8.5 (EPT/RI)
20th Jun 201711:07 amRNSForm 8.5 (EPT/RI)
20th Jun 201710:10 amRNSForm 8.3 - EXOVA PLC
19th Jun 20171:51 pmRNSForm 8.3 - Exova Group Plc
19th Jun 201710:45 amRNSForm 8.5 (EPT/RI)
16th Jun 201712:20 pmRNSForm 8.3 - Exova Group Plc
16th Jun 201711:08 amRNSForm 8.5 (EPT/RI)
16th Jun 20179:48 amRNSForm 8.3 - Exova Group PLC
15th Jun 20173:17 pmRNSForm 8.3 - Exova Group Plc
15th Jun 20173:08 pmRNSForm 8.5 (EPT/RI) - Amendment
15th Jun 20172:55 pmRNSTR-1: Notification of Major Interest in Shares
15th Jun 20171:54 pmRNSForm 8.3 - Exova Group Plc
15th Jun 201711:18 amRNSForm 8.5 (EPT/RI)
15th Jun 20179:52 amRNSForm 8.3 - EXOVA GROUP PLC
14th Jun 20173:30 pmRNSForm 8.3 - EXO LN
14th Jun 201712:14 pmRNSForm 8.3 - EXOVA GROUP PLC
14th Jun 201710:38 amRNSForm 8.5 (EPT/RI)
13th Jun 20174:09 pmRNSTR-1: Notification of Major Interest in Shares
13th Jun 20173:30 pmRNSForm 8.3 - EXO LN
13th Jun 201711:28 amRNSForm 8.5 (EPT/RI)
13th Jun 20179:13 amRNSForm 8.3 - EXOVA GROUP PLC
12th Jun 20173:30 pmRNSForm 8.3 - EXO LN

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.